These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
43. Effect of Cilostazol on Cerebral Vasospasm and Outcome in Patients with Aneurysmal Subarachnoid Hemorrhage: A Randomized, Double-Blind, Placebo-Controlled Trial. Matsuda N; Naraoka M; Ohkuma H; Shimamura N; Ito K; Asano K; Hasegawa S; Takemura A Cerebrovasc Dis; 2016; 42(1-2):97-105. PubMed ID: 27070952 [TBL] [Abstract][Full Text] [Related]
44. Preventive effect of continuous cisternal irrigation with magnesium sulfate solution on angiographic cerebral vasospasms associated with aneurysmal subarachnoid hemorrhages: a randomized controlled trial. Yamamoto T; Mori K; Esaki T; Nakao Y; Tokugawa J; Watanabe M J Neurosurg; 2016 Jan; 124(1):18-26. PubMed ID: 26230471 [TBL] [Abstract][Full Text] [Related]
45. Nimodipine in aneurysmal subarachnoid hemorrhage: a randomized study of intravenous or peroral administration. Kronvall E; Undrén P; Romner B; Säveland H; Cronqvist M; Nilsson OG J Neurosurg; 2009 Jan; 110(1):58-63. PubMed ID: 18847340 [TBL] [Abstract][Full Text] [Related]
46. Nimodipine after aneurysmal subarachnoid hemorrhage: Fourteen-day course for patients that meet criteria for early hospital discharge. Sokolowski JD; Chen CJ; Soldozy S; Mastorakos P; Burke RM; Nguyen JM; Myers KM; Kalani MYS; Park MS Clin Neurol Neurosurg; 2021 Jan; 200():106299. PubMed ID: 33092929 [TBL] [Abstract][Full Text] [Related]
47. Treatment of Cerebral Vasospasm With Continuous Intra-Arterial Nimodipine: A Case Report. Barbosa S; Jorge N; Silva ML; Maia I; Dias C; Pereira E; Paiva JA Cureus; 2022 Oct; 14(10):e30507. PubMed ID: 36415418 [TBL] [Abstract][Full Text] [Related]
48. Hemodynamic response and clinical outcome following intravenous milrinone plus norepinephrine-based hyperdynamic hypertensive therapy in patients suffering secondary cerebral ischemia after aneurysmal subarachnoid hemorrhage. Steiger HJ; Ensner R; Andereggen L; Remonda L; Berberat J; Marbacher S Acta Neurochir (Wien); 2022 Mar; 164(3):811-821. PubMed ID: 35138488 [TBL] [Abstract][Full Text] [Related]
49. Feasibility and safety of intrathecal nimodipine on posthaemorrhagic cerebral vasospasm refractory to medical and endovascular therapy. Hänggi D; Beseoglu K; Turowski B; Steiger HJ Clin Neurol Neurosurg; 2008 Sep; 110(8):784-90. PubMed ID: 18554777 [TBL] [Abstract][Full Text] [Related]
50. A multimodal concept in patients after severe aneurysmal subarachnoid hemorrhage: results of a controlled single centre prospective randomized multimodal phase I/II trial on cerebral vasospasm. Hänggi D; Eicker S; Beseoglu K; Behr J; Turowski B; Steiger HJ Cent Eur Neurosurg; 2009 May; 70(2):61-7. PubMed ID: 19711257 [TBL] [Abstract][Full Text] [Related]
51. Influence of nimodipine combined with ulinastatin on neurological function and inflammatory reaction in patients with cerebral vasospasm after subarachnoid hemorrhage. Chen M; Zhang Q; Liu H; Zou W; Wei X Clin Neurol Neurosurg; 2021 Nov; 210():106981. PubMed ID: 34700272 [TBL] [Abstract][Full Text] [Related]
52. Cerebral vasospasm and health-related quality of life after subarachnoid hemorrhage. Tjahjadi M; König R; Wirtz CR; Woischneck D; Kapapa T World Neurosurg; 2013; 80(1-2):113-20. PubMed ID: 23022640 [TBL] [Abstract][Full Text] [Related]
53. Continuous intra-arterial infusion of nimodipine during embolization of cerebral aneurysms associated with vasospasm. Oran I; Cinar C AJNR Am J Neuroradiol; 2008 Feb; 29(2):291-5. PubMed ID: 17989369 [TBL] [Abstract][Full Text] [Related]
54. Effect of statin treatment on vasospasm-related morbidity and functional outcome in patients with aneurysmal subarachnoid hemorrhage: a systematic review and meta-analysis. Shen J; Huang KY; Zhu Y; Pan JW; Jiang H; Weng YX; Zhan RY J Neurosurg; 2017 Aug; 127(2):291-301. PubMed ID: 27715439 [TBL] [Abstract][Full Text] [Related]
56. Temporal evolution of vasospasm and clinical outcome after intra-arterial vasodilator therapy in patients with aneurysmal subarachnoid hemorrhage. Daftari Besheli L; Tan CO; Bell DL; Hirsch JA; Gupta R PLoS One; 2017; 12(3):e0174676. PubMed ID: 28339483 [TBL] [Abstract][Full Text] [Related]
57. Outcome of Oral and Intra-arterial Nimodipine Administration After Aneurysmal Subarachnoid Haemorrhage - A Single-centre Study. Ehrlich G; Kirschning T; Wenz H; Hegewald AA; Neumaier-Probst E; Seiz-Rosenhagen M In Vivo; 2019; 33(6):1967-1975. PubMed ID: 31662526 [TBL] [Abstract][Full Text] [Related]
58. Immediate angiographic control after intra-arterial nimodipine administration underestimates the vasodilatory effect. Zaeske C; Zopfs D; Laukamp K; Lennartz S; Kottlors J; Goertz L; Stetefeld H; Hof M; Abdullayev N; Kabbasch C; Schlamann M; Schönfeld M Sci Rep; 2024 Mar; 14(1):6154. PubMed ID: 38486099 [TBL] [Abstract][Full Text] [Related]
59. Pharmacologic Management of Cerebral Vasospasm in Aneurysmal Subarachnoid Hemorrhage. Smetana KS; Buschur PL; Owusu-Guha J; May CC Crit Care Nurs Q; 2020; 43(2):138-156. PubMed ID: 32084059 [TBL] [Abstract][Full Text] [Related]
60. Continuous intra-arterial dilatation with nimodipine and milrinone for refractory cerebral vasospasm. Anand S; Goel G; Gupta V J Neurosurg Anesthesiol; 2014 Jan; 26(1):92-3. PubMed ID: 23774116 [No Abstract] [Full Text] [Related] [Previous] [Next] [New Search]